The role of androgen receptor (AR) in urothelial carcinoma of the ureter and renal pelvis remains unclear; however, AR has been demonstrated to affect urothelial carcinoma of the bladder (15). The gene discussed is AR; the disease is bladder transitional cell carcinoma.